QHC Pengajuan SEC - Quorum Health Corporation- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

LEI	549300PO3E4YREFT1I57
CIK	1650445

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Quorum Health Corporation

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

July 10, 2020	SC 13D/A	QHC / Quorum Health Corporation / Mudrick Capital Management, L.P. - AMENDMENT NO. 4 TO THE SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 4)1 Quorum Health Corporation (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 74909E106 (CUSIP Number) STEVE WOLOSKY, ESQ.
July 9, 2020	SC 13D/A	QHC / Quorum Health Corporation / DAVIDSON KEMPNER PARTNERS - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D under the Securities Exchange Act of 1934 (Amendment No. 4) Quorum Health Corporation (Name of Issuer) Common Stock, Par Value $0.0001 (Title of Class of Securities) 74909E106 (CUSIP Number) Shulamit Leviant, Esq. Davidson Kempner Capital Management LP 520 Madison Avenue, 30th Floor New York, NY 10022 (21
July 9, 2020	SC 13D/A	QHC / Quorum Health Corporation / KKR Asset Management LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934* (Amendment No. 6) Quorum Health Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 74909E106 (CUSIP Number) David J. Sorkin, Esq. Kohlberg Kravis Roberts & Co. L.P. 9 West 57th Street, Suite 4200 New York, NY 10019 (212)
July 7, 2020	S-8 POS	- FORM S-8 POS Form S-8 POS As filed with the Securities and Exchange Commission on July 7, 2020 Registration No.
July 7, 2020	EX-2.1	Debtors’ Joint Prepackaged Chapter 11 Plan of Reorganization, dated as of April 7, 2020, as amended or supplemented on April 27, 2020, June 5, 2020, June 12, 2020, and June 30, 2020 EX-2.1 Exhibit 2.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE In re: QUORUM HEALTH CORPORATION, et al., Debtors.1 ) ) ) ) ) ) ) ) Chapter 11 Case No. 20-10766 (KBO) Jointly Administered Related to Docket No. 21, 470 DEBTORS’ JOINT PREPACKAGED CHAPTER 11 PLAN OF REORGANIZATION THIS CHAPTER 11 PLAN IS BEING SOLICITED FOR ACCEPTANCE OR REJECTION IN ACCORDANCE WITH BANKRUPTCY C
July 7, 2020	S-8 POS	- FORM S-8 POS Form S-8 POS As filed with the Securities and Exchange Commission on July 7, 2020 Registration No.
July 7, 2020	S-8 POS	- FORM S-8 POS Form S-8 POS As filed with the Securities and Exchange Commission on July 7, 2020 Registration No.
July 7, 2020	EX-99.3	Quorum Summary Projections Note: Adjusted EBITDA is a non-GAAP financial measure that consists of net income (loss) before interest, income taxes, depreciation and amortization, and is adjusted to add back the effect of certain legal, professional an EX-99.3 CLEANSING MATERIALS These materials have been prepared for the creditors (the “Creditors”) to Quorum Health Corporation (the “Company”) to whom such materials are directly addressed and delivered and may not be used of relied upon for any purpose other than as specifically contemplated by a written agreement. These materials are based on information provided by or on behalf of the Company
July 7, 2020	EX-99.2	Quorum Health Corporation Completes Financial Restructuring, Appoints Joey Jacobs CEO Company Emerges from Chapter 11 with New Capital Structure and Board EX-99.2 Exhibit 99.2 Quorum Health Corporation Completes Financial Restructuring, Appoints Joey Jacobs CEO Company Emerges from Chapter 11 with New Capital Structure and Board BRENTWOOD, Tenn. (July 7, 2020) – Quorum Health Corporation has successfully completed its financial restructuring and emerged from the Chapter 11 process in U.S. Bankruptcy Court for the District of Delaware. The Company an
July 7, 2020	EX-10.2	Credit Agreement, dated July 7, 2020, among the Term Loan Borrower, the Term Loan Guarantors, the Term Loan Agent, and the lenders party thereto EX-10.2 Exhibit 10.2 Execution Version CREDIT AGREEMENT dated as of July 7, 2020 among QUORUM HEALTH CORPORATION, as the Borrower, QUINCY HEALTH, LLC, as Holdings, THE LENDERS PARTY HERETO and JEFFERIES FINANCE LLC, as Administrative Agent and Collateral Agent Reference is made to the ABL Intercreditor Agreement dated as of July 7, 2020 (as amended, restated, supplemented or otherwise modified fro
July 7, 2020	S-8 POS	- FORM S-8 POS Form S-8 POS As filed with the Securities and Exchange Commission on July 7, 2020 Registration No.
July 7, 2020	S-8 POS	- FORM S-8 POS Form S-8 POS As filed with the Securities and Exchange Commission on July 7, 2020 Registration No.
July 7, 2020	15-12B	- FORM 15-12B Form 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-37550 Quorum Health Corporation (Exact name of registrant a
July 7, 2020	EX-3.1	Second Amended and Restated Certificate of Incorporation of QHC EX-3.1 Exhibit 3.1 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION of QUORUM HEALTH CORPORATION Quorum Health Corporation, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify as follows: 1. The name of the Corporation is Quorum Health Corporation. 2. The Corporation was originally incorporated pursuant to the General Corpor
July 7, 2020	8-K	Regulation FD Disclosure, Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Bankruptcy or Receivership Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 30, 2020 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (C
July 7, 2020	EX-3.2	Second Amended and Restated By-Laws of QHC EX-3.2 Exhibit 3.2 SECOND AMENDED AND RESTATED BY-LAWS of QUORUM HEALTH CORPORATION Adopted and in effect as of July 7, 2020 ARTICLE I OFFICES Section 1.01 Offices. The address of the registered office of Quorum Health Corporation, a Delaware corporation (the “Corporation”) in the State of Delaware shall be in the City of Wilmington, County of New Castle. The Corporation may have other offices, bo
July 7, 2020	EX-10.3	Separation Letter Agreement, dated July 7, 2020, by and between QHC and Robert H. Fish EX-10.3 Exhibit 10.3 [Quorum Health Corporation Letterhead] July 7, 2020 Mr. Robert H. Fish Re: Separation Letter Agreement Dear Mr. Fish: This Separation Letter Agreement (this “Agreement”) shall confirm our understanding with regard to the termination of your (“you” or “your”) employment with Quorum Health Corporation (the “Company”). Reference is made to that certain employment agreement, by an
July 7, 2020	EX-99.1	IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE In re: QUORUM HEALTH CORPORATION, et al., Debtors.1 ) ) ) ) ) ) ) ) Chapter 11 Case No. 20-10766 (KBO) Jointly Administered Related to Docket Nos. 21, 22, 202, 470, 471, 483, and 484. EX-99.1 Exhibit 99.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE In re: QUORUM HEALTH CORPORATION, et al., Debtors.1 ) ) ) ) ) ) ) ) Chapter 11 Case No. 20-10766 (KBO) Jointly Administered Related to Docket Nos. 21, 22, 202, 470, 471, 483, and 484. FINDINGS OF FACT, CONCLUSIONS OF LAW, AND ORDER APPROVING THE DEBTORS’ DISCLOSURE STATEMENT FOR, AND CONFIRMING, THE DEBTORS’ JO
July 7, 2020	EX-10.1	Credit Agreement and Guaranty, dated July 7, 2020, among the ABL Borrowers, the ABL Guarantors, the ABL Agent, as a lender and the collateral agent, and the lenders party thereto EX-10.1 Exhibit 10.1 Execution Version CREDIT AND GUARANTY AGREEMENT Dated as of July 7, 2020 by and among QUORUM HEALTH CORPORATION, as a Borrower, QUINCY HEALTH, LLC, as Holdings, the other Persons party hereto that are designated as Credit Parties, the Lenders from time to time party hereto, and CREDIT SUISSE AG, NEW YORK BRANCH, as Administrative Agent Reference is made to the ABL Intercredito
June 30, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 29, 2020 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (C
June 30, 2020	EX-99.1	Quorum Health Corporation Receives Court Approval to Complete Prepackaged Recapitalization Plan EX-99.1 Exhibit 99.1 Quorum Health Corporation Receives Court Approval to Complete Prepackaged Recapitalization Plan BRENTWOOD, Tenn. (June 29, 2020) – Quorum Health Corporation (the “Company”) has received Court approval of its prepackaged plan to recapitalize the business. The decision paves the way for the Company to complete its financial reorganization and successfully emerge from Chapter 11.
May 15, 2020	10-Q	Quarterly Report - 10-Q S fSep2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number001-37550 QUORUM HEALTH
May 12, 2020	EX-10.1	Engagement Letter, dated April 6, 2020, by and between Quorum Health Corporation and Alvarez & Marsal, LLC EX-10.1 Exhibit 10.1 Alvarez & Marsal North America, LLC 540 West Madison Street – Suite 1800 Chicago, IL 60661 Phone: +1 312 601 4220 Fax: +1 312 332 4599 April 6, 2020 Alfred Lumsdaine Chief Financial Officer Quorum Health Corporation 1573 Mallory Lane Suite #100 Brentwood, TN 37027 Dear Mr. Lumsdaine: This letter confirms and sets forth the terms and conditions of the engagement between Alvarez
May 12, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events 8-K 1 d895392d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 6, 2020 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction o
May 5, 2020	SC 13D/A	QHC / Quorum Health Corporation / Mudrick Capital Management, L.P. - AMENDMENT NO. 3 TO THE SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 3)1 Quorum Health Corporation (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 74909E106 (CUSIP Number) STEVE WOLOSKY, ESQ.
May 5, 2020	SC 13D/A	QHC / Quorum Health Corporation / Mudrick Capital Management, L.P. - EX 99.1 - LETTER TO THE BOARD OF DIRECTORS Activist Investment begin 644 ex991to13da311509007050520.pdf M)5!$1BTQ+C4)>+CS],"C,P,R P(&]B:@H\/" O3&EN96%R:7IE9" Q("], M(#4Y,#DW("]((%L@-C8W(#$X.2!=("]/(#,P-R O12 Q-34S,B O3B X("]4 M(#4W-C8R(#X^"F5N9&]B:@H"B @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( HS,#0@,"!O8FH/#P@ M+U1Y<&4@+UA2968@+T9I;'1E7CR[(NOOGGY /+!@H96YD M7!E+T-A M=&%L;VU%E#BO<7!E+U!A9V4O365D:6%";WA;," P(#8Q,B W.3)=
April 29, 2020	SC 13D/A	QHC / Quorum Health Corporation / Mudrick Capital Management, L.P. - EX 99.1 - LETTER TO THE BOARD OF DIRECTORS Activist Investment begin 644 ex991to13da211509007042920.pdf M)5!$1BTQ+C4-)>+CS],-"C$W." P(&]B:@T\/"],:6YE87)I>F5D(#$O3" S M-#%LQ-S@@ M,C==+TEN9F\@,3F4@,C U+U1Y<&4O6%)E9B]76S$@,B Q73X^YF[EFL;#H/6?@4'KIM!1 4^!/\Q?&$2T/)D4&?P\DB3F:,V=.+0\ F:,DZ5/0D6IX2''<8[VH!D/ M5I(33D=D!6LZ[C29RO;4J,K$"[;TH2L,+:E!EG!KA^4Z2F7R1N MW2QD!E@LU;.-"[C2EQ@V7!E+T-A=&%L;V<^/@UE;F1O8FH-,3@P(# @;V)J#3P\+T%R=$)O M>%LP(# @-C$R(#%LP(# @-C$R(#Q%
April 29, 2020	SC 13D/A	QHC / Quorum Health Corporation / Mudrick Capital Management, L.P. - AMENDMENT NO. 2 TO THE SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 2)1 Quorum Health Corporation (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 74909E106 (CUSIP Number) STEVE WOLOSKY, ESQ.
April 22, 2020	EX-99.25	EX-99.25 NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange ('NYSE' or the 'Exchange') hereby notifies the Securities and Exchange Commission (the 'Commission') of its intention to remove the entire class of the common stock ('Common Stock') of Quorum Health Corporation (the 'Company') from listing and registration on the Exchange at the opening of business on May 4, 2020, pursuant to the provisions of Rule 12d2-2(b) because, in the opinion of the Exchange, the Common Stock is no longer suitable for continued listing and trading on the Exchange.
April 14, 2020	SC 13D/A	QHC / Quorum Health Corporation / York Capital Management Global Advisors, LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Quorum Health Corporation (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 74909E106 (CUSIP Number) York Capital Management Global Advisors, LLC 767 Fifth Avenue, 17th Floor New York, New York 10153 Telephone: (21
April 13, 2020	SC 13D/A	QHC / Quorum Health Corporation / DAVIDSON KEMPNER PARTNERS - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D under the Securities Exchange Act of 1934 (Amendment No. 3) Quorum Health Corporation (Name of Issuer) Common Stock, Par Value $0.0001 (Title of Class of Securities) 74909E106 (CUSIP Number) Shulamit Leviant, Esq. Davidson Kempner Capital Management LP 520 Madison Avenue, 30th Floor New York, NY 10022 (21
April 13, 2020	8-K	Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 7, 2020 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (C
April 13, 2020	EX-10.1	Superpriority Secured Debtor-in-Possession Credit Agreement, dated April 10, 2020, by and among the Company, as borrower, certain subsidiaries of the Company from time to time party thereto as guarantors, the lenders party thereto, GLAS USA LLC, as administrative agent, and GLAS Americas LLC, as collateral agent. EX-10.1 Exhibit 10.1 Execution Version SUPERPRIORITY SECURED DEBTOR-IN-POSSESSION CREDIT AGREEMENT dated as of April 10, 2020 among QUORUM HEALTH CORPORATION, a Debtor and Debtor in Possession under Chapter 11 of the Bankruptcy Code, as Borrower, CERTAIN SUBSIDIARIES OF QUORUM HEALTH CORPORATION FROM TIME TO TIME PARTY HERETO, each a Debtor and Debtor in Possession under Chapter 11 of the Bankrupt
April 10, 2020	10-K	QHC / Quorum Health Corporation 10-K - Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37550 QUORUM HEALTH CORPORATION
April 10, 2020	SC 13D/A	EX 99.2 - PRELIMINARY OMNIBUS OBJECTION TO CERTAIN FIRST DAY MOTIONS
April 10, 2020	EX-99.1	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934* (Amendment No. 3) Quorum Health Corporation (Name of Issuer) Exhibit 99.1 April 8, 2020 T. Patrick Tinker, Esq. Office of the United States Trustee for the District of Delaware 844 King Street Suite 2207 Wilmington, DE 19801 Re: In re Quorum Health Corporation (“QHC” or “Company”), Case No. 20-10766 Dear Mr. Tinker: We represent Mudrick Capital Management, L.P. (“Mudrick”), which is the beneficial owner of approximately 15% of QHC’s equity securities. On be
April 10, 2020	EX-4.9	Descriptions of Quorum Health Corporation’s Common Stock Exhibit 4.9 DESCRIPTION OF THE REGISTRANT’S COMMON STOCK REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The common stock of Quorum Health Corporation (the “Company”, “we,” “our” and “us”) is registered under Section 12 of the Securities Exchange Act of 1934, as amended. The following description of our common stock is a summary and does not purport to be complete. It is s
April 10, 2020	EX-21.1	List of Subsidiaries of Quorum Health Corporation. Exhibit 21.1 Quorum Health Corporation SUBSIDIARY LISTING (*) Majority position held in an entity with physicians, non-profit entities or both Alfaro, Ltd. (NV) Ambulance Services of Forrest City, LLC (AR) Ambulance Services of Lexington, Inc. (TN) Ambulance Services of McKenzie, Inc. (TN) Ambulance Services of Tooele, LLC (DE) Anna Clinic Corp (IL) Anna Hospital Corporation (IL) d/b/a Union Count
April 10, 2020	SC 13D/A	QHC / Quorum Health Corporation / DAVIDSON KEMPNER PARTNERS - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D under the Securities Exchange Act of 1934 (Amendment No. 2) Quorum Health Corporation (Name of Issuer) Common Stock, Par Value $0.0001 (Title of Class of Securities) 74909E106 (CUSIP Number) Shulamit Leviant, Esq. Davidson Kempner Capital Management LP 520 Madison Avenue, 30th Floor New York, NY 10022 (21
April 10, 2020	SC 13D/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 1)1 Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 1)1 Quorum Health Corporation (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 74909E106 (CUSIP Number) STEVE WOLOSKY, ESQ.
April 10, 2020	EX-4.4	Third Supplemental Indenture, dated as of February 6, 2020, by and among Quorum Health Corporation, the subsidiaries party thereto and Wilmington Savings Fund Society, FSB (as successor to Regions Bank), as trustee. Exhibit 4.4 Third Supplemental Indenture THIRD SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of February 6, 2020, by and among Quorum Health Corporation, a Delaware corporation (the “Issuer”), the subsidiaries party hereto (the “Guarantors”) and Wilmington Savings Fund Society, FSB (as successor to Regions Bank), as Trustee (the “Trustee”), under the Indenture referred to below.
April 8, 2020	EX-24.4	POWER OF ATTORNEY EX-24.4 3 d913161dex244.htm EXHIBIT 24.4 Exhibit 24.4 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS that GOLDMAN SACHS & CO. LLC (the “Company”) does hereby make, constitute and appoint each of Jamison Yardley and Nathan R. Burby, acting individually, its true and lawful attorney, to execute and deliver in its name and on its behalf whether the Company is acting individually or as represent
April 8, 2020	SC 13D/A	QHC / Quorum Health Corporation / GOLDMAN SACHS GROUP INC - AMENDMENT NO. 1 TO SCHEDULE 13D Activist Investment Amendment No. 1 to Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Quorum Health Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 74909E106 (CUSIP Number) David S. Thomas, Esq. Goldman Sachs & Co. LLC 200 West Street New York, NY 10282
April 8, 2020	EX-24.3	POWER OF ATTORNEY Exhibit 24.3 Exhibit 24.3 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS that THE GOLDMAN SACHS GROUP, INC. (the “Company”) does hereby make, constitute and appoint each of Jamison Yardley and Nathan R. Burby, acting individually, its true and lawful attorney, to execute and deliver in its name and on its behalf whether the Company is acting individually or as representative of others, any a
April 8, 2020	SC 13D/A	QHC / Quorum Health Corporation / KKR Asset Management LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934* (Amendment No. 5) Quorum Health Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 74909E106 (CUSIP Number) David J. Sorkin, Esq. Kohlberg Kravis Roberts & Co. L.P. 9 West 57th Street, Suite 4200 New York, NY 10019 (212)
April 7, 2020	EX-99.1	Quorum Health Corporation Reaches Agreement with Majority of Lenders and Noteholders on Prepackaged Recapitalization Plan Company Hospital Facilities Are Unaffected, Open and Continue to Provide Patient Care Financial Recapitalization Plan will Signi EX-99.1 Exhibit 99.1 Quorum Health Corporation Reaches Agreement with Majority of Lenders and Noteholders on Prepackaged Recapitalization Plan Company Hospital Facilities Are Unaffected, Open and Continue to Provide Patient Care Financial Recapitalization Plan will Significantly Reduce Size and Cost of Debt to Better Position Quorum and its Hospitals for Long-term Growth BRENTWOOD, Tenn. – April 7
April 7, 2020	EX-10.2	Equity Commitment Agreement, dated April 6 2020, by and among the Company and certain of the holders of its unsecured senior notes EX-10.2 Exhibit 10.2 EQUITY COMMITMENT AGREEMENT AMONG QUORUM HEALTH CORPORATION AND THE EQUITY COMMITMENT PARTIES PARTY HERETO Dated as of April 6, 2020 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS Section 1.01. Definitions 2 Section 1.02. Additional Defined Terms 10 Section 1.03. Construction 11 ARTICLE 2 EQUITY COMMITMENT Section 2.01. The Equity Commitment 12 Section 2.02. Equity Commitment Pa
April 7, 2020	EX-99.2	IN THE UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE In re: QUORUM HEALTH CORPORATION, et al.,1 Debtors. ) ) ) ) ) ) ) Chapter 11 Case No. 20-[_______] (___) (Joint Administration Requested) DISCLOSURE STATEMENT FOR THE DEBTORS’ JOINT PREPACKAG EX-99.2 Exhibit 99.2 IN THE UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE In re: QUORUM HEALTH CORPORATION, et al.,1 Debtors. ) ) ) ) ) ) ) Chapter 11 Case No. 20-[] () (Joint Administration Requested) DISCLOSURE STATEMENT FOR THE DEBTORS’ JOINT PREPACKAGED CHAPTER 11 PLAN OF REORGANIZATION Felicia Gerber Perlman (pro hac vice admission pending) David R. Hurst (I.D. No. 3743) Bradley Thomas
April 7, 2020	EX-99.3	Pr oject Quincy MNPI Packet April 6, 2020 EX-99.3 Exhibit 99.3 Pr oject Quincy MNPI Packet April 6, 2020 These materials have been prepared for the creditors (the “Creditors”) to Quorum Health Corporation (the “Company”) to whom such materials are directly addressed and delivered and may not be used of relied upon for any purpose other than as specifically contemplated by a written agreement. These materials are based on information provi
April 7, 2020	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Bankruptcy or Receivership Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 6, 2020 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (C
April 7, 2020	EX-10.1	Restructuring Support Agreement, dated April 6 2020, by and among the Company and certain of its creditors party thereto EX-10.1 Exhibit 10.1 EXECUTION VERSION THIS RESTRUCTURING SUPPORT AGREEMENT IS NOT AN OFFER WITH RESPECT TO ANY SECURITIES OR A SOLICITATION OF VOTES WITH RESPECT TO A CHAPTER 11 PLAN OF REORGANIZATION. ANY SUCH OFFER OR SOLICITATION WILL COMPLY WITH ALL APPLICABLE SECURITIES LAWS AND/OR, AS APPLICABLE, PROVISIONS OF THE BANKRUPTCY CODE. RESTRUCTURING SUPPORT AGREEMENT by and among QUORUM HEALTH C
March 31, 2020	NT 10-K	QHC / Quorum Health Corporation NT 10-K - - NT 10-K NT 10-K SEC FILE NUMBER 001-37550 CUSIP NUMBER 74909E106 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 27, 2020	EX-99.1	QUORUM HEALTH CORPORATION RECEIVES NYSE CONTINUED LISTING STANDARD NOTICE EX-99.1 Exhibit 99.1 Investor Contact: Asher Dewhurst Westwicke Partners [email protected] / (443) 213-0500 QUORUM HEALTH CORPORATION RECEIVES NYSE CONTINUED LISTING STANDARD NOTICE BRENTWOOD, Tenn. (March 27, 2020) – Quorum Health Corporation (NYSE: QHC) (the “Company”) today announced that it was notified (the “March 2020 Notice”) on March 23, 2020 by the New York Stock Exchange (the “N
March 27, 2020	8-K	Regulation FD Disclosure, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits 8-K 1 d906023d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 23, 2020 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdictio
March 23, 2020	EX-99.1	JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.0001 per share, of Quorum Health Corporation, a Delaware corpo
March 23, 2020	SC 13D	QHC / Quorum Health Corporation / Mudrick Capital Management, L.P. - THE SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. )1 Quorum Health Corporation (Name of Issuer) Common Stock, par value $0.0001 (Title of Class of Securities) 74909E106 (CUSIP Number) STEVE WOLOSKY, ESQ. O
March 23, 2020	EX-99.2	March 23, 2020 Exhibit 99.2 March 23, 2020 Board of Directors of Quorum Health Corporation 1573 Mallory Lane Brentwood, Tennessee 37027 Attn: Ms. Terry Allison Rappuhn, Chair Re: Quorum Health Corporation (the “Company”) Dear Ms. Rappuhn: We are counsel to Mudrick Capital Management, LP (“Mudrick”), beneficial owner of approximately 10% of the Company’s equity securities. We are deeply troubled by the fact that
March 11, 2020	EX-99.1	QUORUM HEALTH CORPORATION RESPONDS TO AN UPDATE ON POTENTIAL TRANSACTION EX-99.1 Exhibit 99.1 Investor Contact: Asher Dewhurst Westwicke Partners [email protected] / (443) 213-0500 QUORUM HEALTH CORPORATION RESPONDS TO AN UPDATE ON POTENTIAL TRANSACTION BRENTWOOD, Tenn. (March 11, 2020) – Quorum Health Corporation (NYSE: QHC) today responded to an update provided by KKR Credit Advisors (US) LLC (“KKR”) on Tuesday March 10, 2020 regarding the previously disclos
March 11, 2020	8-K	Financial Statements and Exhibits, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 11, 2020 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (
March 10, 2020	EX-99.A	Exhibit A EXHIBIT A JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the shares of common stock, par value $0.
March 10, 2020	SC 13D/A	QHC / Quorum Health Corporation / KKR Asset Management LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934* (Amendment No. 4) Quorum Health Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 74909E106 (CUSIP Number) David J. Sorkin, Esq. Kohlberg Kravis Roberts & Co. L.P. 9 West 57th Street, Suite 4200 New York, NY 10019 (212)
March 10, 2020	EX-99.D	Exhibit D Exhibit D POWER OF ATTORNEY Know all men by these presents that Robert H. Lewin does hereby make, constitute and appoint David J. Sorkin, Terence P. Gallagher, and Christopher Lee, or any one of them, as a true and lawful attorney-in-fact of the undersigned with full powers of substitution and revocation, for and in the name, place and stead of the undersigned (both in the undersigned’s individual
February 5, 2020	SC 13D/A	QHC / Quorum Health Corporation / DAVIDSON KEMPNER PARTNERS - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D under the Securities Exchange Act of 1934 (Amendment No. 1) Quorum Health Corporation (Name of Issuer) Common Stock, Par Value $0.0001 (Title of Class of Securities) 74909E106 (CUSIP Number) Shulamit Leviant, Esq. Davidson Kempner Capital Management LP 520 Madison Avenue, 30th Floor New York, NY 10022 (21
January 31, 2020	SC 13G/A	QHC / Quorum Health Corporation / OAK HILL ADVISORS LP - SCHEDULE 13G HOLDINGS REPORT AMENDMENT Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No.
December 6, 2019	EX-99.1	QUORUM HEALTH CORPORATION RECEIVES NYSE CONTINUED LISTING STANDARD NOTICE EX-99.1 Exhibit 99.1 Investor Contact: Asher Dewhurst Westwicke Partners [email protected] / (443) 213-0500 QUORUM HEALTH CORPORATION RECEIVES NYSE CONTINUED LISTING STANDARD NOTICE BRENTWOOD, Tenn. (December 6, 2019) – Quorum Health Corporation (NYSE: QHC) (the “Company”) today announced that it was notified (the “December Notice”) on December 3, 2019 by the New York Stock Exchange (the
December 6, 2019	8-K	Regulation FD Disclosure, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits 8-K 1 d793069d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 3, 2019 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdict
December 3, 2019	EX-99.1	QUORUM HEALTH CORPORATION CONFIRMS RECEIPT OF LETTER REGARDING POTENTIAL TRANSACTION EX-99.1 Exhibit 99.1 Investor Contact: Asher Dewhurst Westwicke Partners [email protected] / (443) 213-0500 QUORUM HEALTH CORPORATION CONFIRMS RECEIPT OF LETTER REGARDING POTENTIAL TRANSACTION BRENTWOOD, Tenn. (December 2, 2019) – Quorum Health Corporation (NYSE: QHC) today confirmed the receipt of a non-binding proposal letter from KKR Credit Advisors (US) LLC (“KKR”) relating to a poten
December 3, 2019	8-K	Financial Statements and Exhibits, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 2, 2019 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Com
December 2, 2019	SC 13D/A	QHC / Quorum Health Corporation / KKR Asset Management LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934* (Amendment No. 3) Quorum Health Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 74909E106 (CUSIP Number) David J. Sorkin, Esq. Kohlberg Kravis Roberts & Co. L.P. 9 West 57th Street, Suite 4200 New York, NY 10019 (212)
November 7, 2019	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES THIRD QUARTER 2019 RESULTS Third quarter net loss attributable to Quorum Health Corporation was ($75.9) million, or ($2.52) per share Third quarter Adjusted EBITDA was $13.7 million and Same-facility Adjusted EBITD Exhibit 99.1 Investor Contact: Asher Dewhurst Westwicke Partners [email protected] (443) 213-0500 QUORUM HEALTH CORPORATION ANNOUNCES THIRD QUARTER 2019 RESULTS Third quarter net loss attributable to Quorum Health Corporation was ($75.9) million, or ($2.52) per share Third quarter Adjusted EBITDA was $13.7 million and Same-facility Adjusted EBITDA was $30.6 million Full year 2019 Same-fac
November 7, 2019	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 7, 2019 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Commiss
November 7, 2019	10-Q	QHC / Quorum Health Corporation 10-Q - Quarterly Report - 10-Q fSep2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37550 QUORUM HEAL
November 7, 2019	EX-10.1	Amendment No. 1 to Employment Agreement by and between Quorum Health Corporation and Robert H. Fish Exhibit 10.1 QUORUM HEALTH CORPORATION Amendment No. 1 to Employment Agreement Robert H. Fish Effective Date: July 16, 2019 WHEREAS, Quorum Health Corporation (the “Company”) and Robert H. Fish (“Executive”) entered into an Employment Agreement effective as of May 21, 2018 (as amended, restated or otherwise modified from time to time, the “Employment Agreement”); WHEREAS, the Company and Executive
October 31, 2019	8-K/A	Costs Associated with Exit or Disposal Activities Form 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 12, 2019 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction
September 23, 2019	8-K	Regulation FD Disclosure, Termination of a Material Definitive Agreement, Financial Statements and Exhibits Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 23, 2019 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporatio
September 23, 2019	EX-99.1	QUORUM HEALTH CORPORATION, COMMUNITY HEALTH SYSTEMS AGREE TO TERMINATE SHARED SERVICE CENTERS TRANSITION SERVICES AGREEMENT EX-99.1 Exhibit 99.1 Investor Contact: Asher Dewhurst Westwicke Partners [email protected] / (443) 213-0500 QUORUM HEALTH CORPORATION, COMMUNITY HEALTH SYSTEMS AGREE TO TERMINATE SHARED SERVICE CENTERS TRANSITION SERVICES AGREEMENT BRENTWOOD, Tenn. (September 23, 2019) – Quorum Health Corporation (NYSE: QHC) and Community Health Systems, Inc. (“CHS”) today announced that they have reached
September 3, 2019	SC 13D	QHC / Quorum Health Corporation / York Capital Management Global Advisors, LLC - FORM SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Quorum Health Corporation (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 74909E106 (CUSIP Number) York Capital Management Global Advisors, LLC 767 Fifth Avenue, 17th Floor New York, New York 10153 Telephone: (212
August 7, 2019	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES SECOND QUARTER 2019 RESULTS Second quarter net loss attributable to Quorum Health Corporation was ($16.9) million, or ($0.56) per share Second quarter Adjusted EBITDA was $33.4 million and Same-facility Adjusted EB Exhibit 99.1 Investor Contact: Asher Dewhurst Westwicke Partners [email protected] (443) 213-0500 QUORUM HEALTH CORPORATION ANNOUNCES SECOND QUARTER 2019 RESULTS Second quarter net loss attributable to Quorum Health Corporation was ($16.9) million, or ($0.56) per share Second quarter Adjusted EBITDA was $33.4 million and Same-facility Adjusted EBITDA was $36.9 million Announces agreement
August 7, 2019	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 7, 2019 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Commissio
August 7, 2019	EX-10.5	Form of Restricted Stock Agreement under the Quorum Health Corporation 2018 Restricted Stock Plan Exhibit 10.5 QUORUM HEALTH CORPORATION 2018 RESTRICTED STOCK PLAN RESTRICTED STOCK AGREEMENT Pursuant to the terms of the Quorum Health Corporation 2018 Restricted Stock Plan (the "Plan"), and as further set forth herein, you have been granted an Award of Restricted Stock, as follows: Upon and subject to the Additional Terms and Conditions attached hereto and incorporated herein by reference as pa
August 7, 2019	EX-10.1	Quorum Health Corporation Amended and Restated Director’s Fees Deferral Plan. Exhibit 10.1 QUORUM HEALTH CORPORATION AMENDED AND RESTATED DIRECTOR’S FEES DEFERRAL PLAN SECTION 1. Purpose, Participation (a)Purpose. The purpose of this Amended and Restated Director’s Fees Deferral Plan (the “Plan”) is to enable Quorum Health Corporation (the “Corporation”) to attract and retain Directors of outstanding ability by providing them with a mechanism (i) to defer and accumulate Dir
August 7, 2019	10-Q	QHC / Quorum Health Corporation 10-Q - Quarterly Report - 10-Q fSep2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37550 QUORUM HEALTH CO
August 7, 2019	EX-10.4	Form of Time-Based and Performance-Based Restricted Stock Award Agreement under the Quorum Health Corporation Amended and Restated 2016 Stock Award Plan. Exhibit 10.4 TIME-BASED AND PERFORMANCE-BASED RESTRICTED STOCK AWARD AGREEMENT Quorum Health Corporation Amended and Restated 2016 Stock Award Plan THIS AGREEMENT between you and Quorum Health Corporation, a Delaware corporation (the “Company”), governs an Award of the Company’s Restricted Stock in the amount and on the date specified in your Award notification (the “Grant Date”). WHEREAS, the Com
August 7, 2019	EX-10.2	Form of Restricted Stock Award Agreement under the Quorum Health Corporation Amended and Restated 2016 Stock Award Plan Exhibit 10.2 RESTRICTED STOCK AWARD AGREEMENT Quorum Health Corporation Amended and Restated 2016 Stock Award Plan THIS AGREEMENT between you and Quorum Health Corporation, a Delaware corporation (the “Company”), governs an Award of the Company’s Restricted Stock in the amount and on the date specified in your Award notification (the “Grant Date”). WHEREAS, the Company has adopted the Quorum Healt
August 7, 2019	EX-10.3	Form of Non-Employee Director Restricted Stock Award Agreement under the Quorum Health Corporation Amended and Restated 2016 Stock Award Plan. Exhibit 10.3 NON-EMPLOYEE DIRECTOR RESTRICTED STOCK AWARD AGREEMENT Quorum Health Corporation Amended and Restated 2016 Stock Award Plan THIS AGREEMENT between you and Quorum Health Corporation, a Delaware corporation (the “Company”), governs an Award of the Company’s Restricted Stock in the amount and on the date specified in your Award notification (the “Grant Date”). WHEREAS, the Company has ad
July 12, 2019	SC 13G	QHC / Quorum Health Corporation / OAK HILL ADVISORS LP - SCHEDULE 13G HOLDINGS REPORT Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.
July 12, 2019	SC 13G	QHC / Quorum Health Corporation / OAK HILL ADVISORS LP - SCHEDULE 13G HOLDINGS REPORT Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.
June 12, 2019	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Costs Associated with Exit or Disposal Activities, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 12, 2019 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Commis
June 12, 2019	EX-99.1	QUORUM HEALTH CORPORATION DISCONTINUES INPATIENT OPERATIONS AT A HOSPITAL IN ILLINOIS EX-99.1 Exhibit 99.1 Investor Contact: Asher Dewhurst Westwicke Partners [email protected] / (443) 213-0500 QUORUM HEALTH CORPORATION DISCONTINUES INPATIENT OPERATIONS AT A HOSPITAL IN ILLINOIS BRENTWOOD, Tenn. (June 12, 2019) – Quorum Health Corporation (NYSE: QHC) today announced that MetroSouth Medical Center in Blue Island, Illinois filed an application with the Illinois Health Facili
June 7, 2019	8-K	Financial Statements and Exhibits, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 7, 2019 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Co
June 7, 2019	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES DEFINITIVE AGREEMENT TO DIVEST A HOSPITAL IN CALIFORNIA EX-99.1 Exhibit 99.1 Investor Contact: Asher Dewhurst Westwicke Partners [email protected] / (443) 213-0500 QUORUM HEALTH CORPORATION ANNOUNCES DEFINITIVE AGREEMENT TO DIVEST A HOSPITAL IN CALIFORNIA BRENTWOOD, Tenn. (June 7, 2019) – Quorum Health Corporation (NYSE: QHC) today announced that it has entered into a definitive agreement to divest the 106-bed Watsonville Community Hospital in
May 31, 2019	8-K	Submission of Matters to a Vote of Security Holders Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 31, 2019 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Co
May 10, 2019	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 10, 2019 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Commission
May 10, 2019	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES FIRST QUARTER 2019 RESULTS First quarter net loss attributable to Quorum Health Corporation was ($39.0) million, or ($1.33) per share First quarter Adjusted EBITDA was $20.6 million and Same-facility Adjusted EBITD Exhibit 99.1 Investor Contact: Asher Dewhurst Westwicke Partners [email protected] (443) 213-0500 QUORUM HEALTH CORPORATION ANNOUNCES FIRST QUARTER 2019 RESULTS First quarter net loss attributable to Quorum Health Corporation was ($39.0) million, or ($1.33) per share First quarter Adjusted EBITDA was $20.6 million and Same-facility Adjusted EBITDA was $23.5 million Revenue cycle managemen
May 10, 2019	10-Q	QHC / Quorum Health Corporation 10-Q Quarterly Report 10-Q fSep2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37550 QUORUM HEALTH C
May 3, 2019	EX-99.1	QUORUM HEALTH CORPORATION RECEIVES NYSE CONTINUED LISTING STANDARD NOTICE EX-99.1 Exhibit 99.1 Investor Contact: Asher Dewhurst Westwicke Partners [email protected] / (443) 213-0500 QUORUM HEALTH CORPORATION RECEIVES NYSE CONTINUED LISTING STANDARD NOTICE BRENTWOOD, Tenn. (May 3, 2019) – Quorum Health Corporation (NYSE: QHC) (the “Company”) today announced that it was notified (the “Notice”) on April 30, 2019 by the New York Stock Exchange, Inc. (the “NYSE”) th
May 3, 2019	8-K	Regulation FD Disclosure, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 30, 2019 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (
April 26, 2019	SC 13D	QHC / Quorum Health Corporation / GOLDMAN SACHS GROUP INC - SCHEDULE 13D Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Quorum Health Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 74909E106 (CUSIP Number) David S. Thomas, Esq. Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 (212) 902-1000 (Name
April 26, 2019	EX-24.1	POWER OF ATTORNEY Exhibit 24.1 EXHIBIT 24.1 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS that THE GOLDMAN SACHS GROUP, INC. (the “Company”) does hereby make, constitute and appoint each of Jamison Yardley, Jennifer G. Lee and Jess J. Morrison, acting individually, its true and lawful attorney, to execute and deliver in its name and on its behalf, whether the Company is acting individually or as representati
April 26, 2019	EX-99.1	JOINT FILING AGREEMENT Exhibit 99.1 EXHIBIT 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the common stock, $0.0001 par value per share, of QUORUM HEALTH CORPORATION and further agree to the filing of this agreement as
April 26, 2019	EX-24.2	POWER OF ATTORNEY Exhibit 24.2 EXHIBIT 24.2 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS that GOLDMAN SACHS & CO. LLC (the “Company”) does hereby make, constitute and appoint each of Jamison Yardley, Jennifer G. Lee and Jess J. Morrison, acting individually, its true and lawful attorney, to execute and deliver in its name and on its behalf, whether the Company is acting individually or as representative of
April 19, 2019	DEFA14A	QHC / Quorum Health Corporation DEFA14A DEFA14A 1 d701768ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule
April 19, 2019	DEF 14A	QHC / Quorum Health Corporation DEF 14A DEF 14A 1 d701768ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as
April 12, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 10, 2019 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (
April 11, 2019	EX-99.A	Joint Filing Agreement Exhibit A Exhibit A Joint Filing Agreement This will confirm the agreement by and among the undersigned that the Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the shares of common stock, par value $0.
April 11, 2019	SC 13D	QHC / Quorum Health Corporation / DAVIDSON KEMPNER PARTNERS - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D under the Securities Exchange Act of 1934 (Amendment No. ) Quorum Health Corporation (Name of Issuer) Common Stock, Par Value $0.0001 (Title of Class of Securities) 74909E106 (CUSIP Number) Shulamit Leviant, Esq. Davidson Kempner Capital Management LP 520 Madison Avenue, 30th Floor New York, NY 10022 (212)
March 19, 2019	SC 13G	QHC / Quorum Health Corporation / York Capital Management Global Advisors, LLC - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (AMENDMENT NO. )* Quorum Health Corporation (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 74909E106 (CUSIP Number) December 31, 2
March 12, 2019	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES FOURTH QUARTER 2018 RESULTS AND PROVIDES 2019 GUIDANCE Full year net loss attributable to Quorum Health Corporation was ($200.2) million, or ($6.91) per share Full year Adjusted EBITDA was $126.4 million and Adjust Exhibit 99.1 Investor Contact: Asher Dewhurst Westwicke Partners [email protected] (443) 213-0500 QUORUM HEALTH CORPORATION ANNOUNCES FOURTH QUARTER 2018 RESULTS AND PROVIDES 2019 GUIDANCE Full year net loss attributable to Quorum Health Corporation was ($200.2) million, or ($6.91) per share Full year Adjusted EBITDA was $126.4 million and Adjusted EBITDA, Adjusted for Divestitures was $1
March 12, 2019	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 12, 2019 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Commissio
March 12, 2019	EX-21.1	List of Subsidiaries of Quorum Health Corporation. Exhibit 21.1 Quorum Health Corporation SUBSIDIARY LISTING (*) Majority position held in an entity with physicians, non-profit entities or both Alfaro, Ltd. (NV) Ambulance Services of Forrest City, LLC (AR) Ambulance Services of Lexington, Inc. (TN) Ambulance Services of McKenzie, Inc. (TN) Ambulance Services of Tooele, LLC (DE) Anna Clinic Corp (IL) Anna Hospital Corporation (IL) d/b/a Union Count
March 12, 2019	10-K	QHC / Quorum Health Corporation 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37550 QUORUM HEALTH CORPORATION
February 15, 2019	S-8	QHC / Quorum Health Corporation FORM S-8 Form S-8 As filed with the Securities and Exchange Commission on February 14, 2019 Registration No.
February 15, 2019	EX-4.1	Quorum Health Corporation Amended and Restated 2016 Stock Award Plan. EX-4.1 Exhibit 4.1 QUORUM HEALTH CORPORATION AMENDED AND RESTATED 2016 STOCK AWARD PLAN 1. Purpose. The purpose of this Plan is to strengthen Quorum Health Corporation, a Delaware corporation (the “Company”), and its Subsidiaries by providing a retention tool and an incentive to its and their employees, officers, consultants and directors and thereby encouraging them to devote their abilities and
February 8, 2019	SC 13G/A	QHC / Quorum Health Corporation / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* QUORUM HEALTH CORP (Name of Issuer) Common Stock (Title of Class of Securities) 74909E106 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sche
January 7, 2019	8-K	Regulation FD Disclosure, Financial Statements and Exhibits Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 7, 2019 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation)
January 7, 2019	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES FINAL RULING IN THE ARBITRATION WITH COMMUNITY HEALTH SYSTEMS EX-99.1 Exhibit 99.1 Investor Contact: Asher Dewhurst Westwicke Partners [email protected] / (443) 213-0500 QUORUM HEALTH CORPORATION ANNOUNCES FINAL RULING IN THE ARBITRATION WITH COMMUNITY HEALTH SYSTEMS BRENTWOOD, Tenn. (January 7, 2019) – Quorum Health Corporation (NYSE: QHC) today announced that it has received a final ruling from the American Arbitration Association regarding its pr
December 19, 2018	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 17, 2018 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation
December 19, 2018	EX-10.2	Form of Restricted Stock Agreement.* EX-10.2 Exhibit 10.2 QUORUM HEALTH CORPORATION 2018 RESTRICTED STOCK PLAN RESTRICTED STOCK AGREEMENT TO PARTICIPANT: Pursuant to the terms of the Quorum Health Corporation 2018 Restricted Stock Plan (the “Plan”), and as further set forth herein, you have been granted an Award of Restricted Stock, as follows: Upon and subject to the Additional Terms and Conditions attached hereto and incorporated h
December 19, 2018	EX-4.1	Quorum Health Corporation 2018 Restricted Stock Plan (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement on Form S-8 filed with the SEC on December 19, 2018) (File No. 333-228885) EX-4.1 Exhibit 4.1 QUORUM HEALTH CORPORATION 2018 RESTRICTED STOCK PLAN 1. Purpose. The purposes of this Quorum Health Corporation 2018 Restricted Stock Plan (the “Plan”) are (a) to encourage certain key employees to continue employment with Quorum Health Corporation (the “Company”) and its subsidiaries (“Affiliates”), and (b) to furnish maximum incentive to those persons to improve operations and
December 19, 2018	S-8	QHC / Quorum Health Corporation FORM S-8 Form S-8 As filed with the Securities and Exchange Commission on December 18, 2018 Registration No.
December 6, 2018	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits 8-K 1 d633833d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 30, 2018 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdic
November 6, 2018	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES THIRD QUARTER 2018 FINANCIAL AND OPERATING RESULTS Exhibit 99.1 Investor Contact: Asher Dewhurst Westwicke Partners [email protected] (443) 213-0500 QUORUM HEALTH CORPORATION ANNOUNCES THIRD QUARTER 2018 FINANCIAL AND OPERATING RESULTS BRENTWOOD, Tenn. (November 6, 2018) – Quorum Health Corporation (NYSE: QHC) (the “Company”) today announced financial and operating results for the third quarter ended September 30, 2018. Third Quarter 2018
November 6, 2018	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 qhc-8k20181106.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 6, 2018 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdicti
November 6, 2018	10-Q	QHC / Quorum Health Corporation 10-Q (Quarterly Report) fSep2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37550 QUORUM HEAL
September 28, 2018	8-K/A	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 7, 2018 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
September 28, 2018	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Unregistered Sales of Equity Securities, Financial Statements and Exhibits Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 27, 2018 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
September 28, 2018	EX-10.2	Form of Inducement Award Performance-Based Restricted Stock Award Agreement EX-10.2 Exhibit 10.2 INDUCEMENT AWARD PERFORMANCE BASED RESTRICTED STOCK AWARD AGREEMENT Quorum Health Corporation THIS AGREEMENT between you and Quorum Health Corporation, a Delaware corporation (the “Company”) governs an Award of the Company’s Restricted Stock in the amount and on the date specified in your Award notification (the “Date of Grant”). WHEREAS, the Compensation Committee of the Comp
September 28, 2018	EX-10.1	Form of Inducement Award Restricted Stock Award Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on September 28, 2018) (File No. 001-37550). EX-10.1 Exhibit 10.1 INDUCEMENT AWARD RESTRICTED STOCK AWARD AGREEMENT Quorum Health Corporation THIS AGREEMENT between you and Quorum Health Corporation, a Delaware corporation (the “Company”) governs an Award of the Company’s Restricted Stock in the amount and on the date specified in your Award notification (the “Date of Grant”). WHEREAS, the Compensation Committee of the Company’s Board of Dir
September 28, 2018	EX-10.3	Restricted Stock Inducement Award Agreement, by and between Robert H. Fish and Quorum Health Corporation (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the SEC on September 28, 2018) (File No. 001-37550). EX-10.3 Exhibit 10.3 INDUCEMENT AWARD RESTRICTED STOCK AWARD AGREEMENT Quorum Health Corporation THIS AGREEMENT between you and Quorum Health Corporation, a Delaware corporation (the “Company”) governs an Award of the Company’s Restricted Stock in the amount and on the date specified in your Award notification (the “Date of Grant”). WHEREAS, the Compensation Committee of the Company’s Board of Dir
September 28, 2018	EX-10.4	Performance-Based Restricted Stock Inducement Award Agreement, by and between Robert H. Fish and Quorum Health Corporation (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the SEC on September 28, 2018) (File No. 001-37550). EX-10.4 Exhibit 10.4 INDUCEMENT AWARD PERFORMANCE BASED RESTRICTED STOCK AWARD AGREEMENT Quorum Health Corporation THIS AGREEMENT between you and Quorum Health Corporation, a Delaware corporation (the “Company”) governs an Award of the Company’s Restricted Stock in the amount and on the date specified in your Award notification (the “Date of Grant”). WHEREAS, the Compensation Committee of the Comp
September 28, 2018	EX-99.1	QUORUM HEALTH CORPORATION UPDATES BOARD COMMITTEE ASSIGNMENTS AND EXECUTIVE COMPENSATION EX-99.1 Exhibit 99.1 Investor Contact: Alfred Lumsdaine, (615) 371-4936 Executive Vice President and Chief Financial Officer QUORUM HEALTH CORPORATION UPDATES BOARD COMMITTEE ASSIGNMENTS AND EXECUTIVE COMPENSATION BRENTWOOD, Tenn. (September 28, 2018) – Quorum Health Corporation (NYSE: QHC) announced today that, in connection with the recent appointments of Jon H. Kaplan and William Paul Rutledge
September 10, 2018	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits 8-K 1 d587401d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 10, 2018 (September 7, 2018) QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (Stat
September 10, 2018	EX-99.1	QUORUM HEALTH CORPORATION APPOINTS THREE MEMBERS TO BOARD OF DIRECTORS EX-99.1 Exhibit 99.1 Investor Contact: Alfred Lumsdaine, (615) 371-4936 Executive Vice President and Chief Financial Officer QUORUM HEALTH CORPORATION APPOINTS THREE MEMBERS TO BOARD OF DIRECTORS BRENTWOOD, Tenn. (September 10, 2018) – Quorum Health Corporation (NYSE: QHC) announced today that its Board of Directors has appointed Jon H. Kaplan and William Paul Rutledge as independent, non-employee
August 25, 2018	EX-99.1	QUORUM HEALTH CORPORATION APPOINTS GLENN HARGREAVES AS CHIEF ACCOUNTING OFFICER EX-99.1 Exhibit 99.1 Investor Contact: Alfred Lumsdaine, (615) 371-4936 Executive Vice President and Chief Financial Officer QUORUM HEALTH CORPORATION APPOINTS GLENN HARGREAVES AS CHIEF ACCOUNTING OFFICER BRENTWOOD, Tenn. (August 24, 2018) – Quorum Health Corporation (NYSE: QHC) today announced that the Company has appointed Glenn A. Hargreaves as Senior Vice President and Chief Accounting Officer
August 25, 2018	EX-10.2	Offer Letter by and between QHCCS, LLC and Glenn A. Hargreaves (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on August 27, 2018) (File No. 001-37550). EX-10.2 Exhibit 10.2 June 7, 2018 Via Email Delivery Glenn Hargreaves 1229 Kilrush Drive Franklin, TN 37069 Dear Glenn: I am pleased to confirm our employment offer for you to join QHCCS, LLC, an affiliate of Quorum Health Corporation (hereinafter referred to as either Quorum Health or Quorum) in the position of Senior Vice President and Chief Accounting Officer and Controller, reporting to Alfred
August 25, 2018	EX-10.1	Employment Agreement by and between Quorum Health Corporation and Robert H. Fish EX-10.1 Exhibit 10.1 EMPLOYMENT AGREEMENT AGREEMENT by and between Quorum Health Corporation (the “Company”) and Robert H. Fish (“Executive”), effective as of the 21st day of May, 2018 (the “Effective Date”). WHEREAS, the Company wishes to employ Executive on the terms and conditions, and for the consideration, hereinafter set forth, and Executive is desirous of being employed by the Company on su
August 25, 2018	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits 8-K 1 d579538d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 24, 2018 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction
August 9, 2018	10-Q	QHC / Quorum Health Corporation 10-Q (Quarterly Report) fSep2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37550 QUORUM HEALTH CO
August 8, 2018	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 8, 2018 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Commissio
August 8, 2018	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES SECOND QUARTER 2018 FINANCIAL AND OPERATING RESULTS Exhibit 99.1 Investor Contact: Alfred Lumsdaine Executive Vice President and Chief Financial Officer (615) 221-4936 QUORUM HEALTH CORPORATION ANNOUNCES SECOND QUARTER 2018 FINANCIAL AND OPERATING RESULTS BRENTWOOD, Tenn. (August 8, 2018) – Quorum Health Corporation (NYSE: QHC) (the “Company”) today announced its financial and operating results for the three and six months ended June 30, 2018. Seco
July 27, 2018	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES DEFINITIVE AGREEMENT TO DIVEST A HOSPITAL IN TENNESSEE EX-99.1 Exhibit 99.1 Investor Contact: Alfred Lumsdaine, (615) 371-4936 Executive Vice President and Chief Financial Officer QUORUM HEALTH CORPORATION ANNOUNCES DEFINITIVE AGREEMENT TO DIVEST A HOSPITAL IN TENNESSEE BRENTWOOD, Tenn. (July 27, 2018) – Quorum Health Corporation (NYSE: QHC) today announced that it had entered into a definitive agreement with Baptist Memorial Health Care regarding the
July 27, 2018	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Costs Associated with Exit or Disposal Activities, Other Events 8-K 1 d591062d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 27, 2018 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of i
June 8, 2018	8-K	Submission of Matters to a Vote of Security Holders 8-K 1 d604952d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 8, 2018 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction
May 24, 2018	EX-99.1	Robert Fish Appointed Interim Chief Executive Officer Thomas Miller Retires as President and Chief Executive Officer EX-99.1 Exhibit 99.1 Quorum Health Corporation Announces Leadership Transition Robert Fish Appointed Interim Chief Executive Officer Thomas Miller Retires as President and Chief Executive Officer BRENTWOOD, Tenn.—(BUSINESS WIRE)—May 21, 2018— Quorum Health Corporation (NYSE: QHC) today announced that the Board of Directors has appointed Robert H. Fish as Interim Chief Executive Officer, effective
May 24, 2018	EX-10.1	Separation and Release Agreement, dated May 20, 2018, between QHCCS, LLC d/b/a Quorum Health and Thomas D. Miller EX-10.1 Exhibit 10.1 Execution Copy SEPARATION AND RELEASE AGREEMENT THIS SEPARATION AND RELEASE AGREEMENT (“Agreement”) is between Thomas D. Miller (the “Employee”) and QHCCS, LLC, dba Quorum Health (the “Employer”). In consideration of the mutual promises and covenants in this Agreement, the Employee and the Employer contract as follows: 1. Cessation of Employment. The Employee acknowledges that
May 24, 2018	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events 8-K 1 d576742d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 23, 2018 (May 20, 2018) QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other
May 24, 2018	EX-10.2	Consultancy Agreement, dated May 20, 2018, by and between QHCCS, LLC and Thomas D. Miller EX-10.2 Exhibit 10.2 Execution Copy CONSULTANCY AGREEMENT Thomas D. Miller This Consultancy Agreement (“Agreement”) is entered into by and between QHCCS, LLC a Delaware corporation (“QHCCS”), and Thomas D. Miller (“Consultant”). 1. Work to Be Performed. It is necessary and/or advisable to promote the interests of QHCCS and associated entities that Consultant provides ongoing consulting services fo
May 17, 2018	EX-99.1	Earnings Presentation First Quarter 2018 May 2018 Investor Presentation EX-99.1 Exhibit 99.1 Earnings Presentation First Quarter 2018 May 2018 Investor Presentation Forward Looking Statements & Non-GAAP Financial Measures Except as otherwise indicated or unless the context otherwise requires, all references in this presentation to “we,” “our,” “us,” “QHC,” the “Company” or “Quorum Health” refer to Quorum Health Corporation and its subsidiaries. Forward-Looking Stateme
May 17, 2018	8-K	Regulation FD Disclosure, Financial Statements and Exhibits Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 17, 2018 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
May 10, 2018	10-Q	QHC / Quorum Health Corporation 10-Q (Quarterly Report) fSep2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37550 QUORUM HEALTH C
May 9, 2018	8-K/A	Costs Associated with Exit or Disposal Activities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 5, 2018 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorp
May 9, 2018	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 9, 2018 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Commission f
May 9, 2018	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES FIRST QUARTER 2018 FINANCIAL AND OPERATING RESULTS Exhibit 99.1 Investor Contact: Alfred Lumsdaine Executive Vice President and Chief Financial Officer (615) 221-4936 QUORUM HEALTH CORPORATION ANNOUNCES FIRST QUARTER 2018 FINANCIAL AND OPERATING RESULTS BRENTWOOD, Tenn. (May 9, 2018) – Quorum Health Corporation (NYSE: QHC) (the “Company”) today announced its financial and operating results for the three months ended March 31, 2018. First Quarter 2
April 27, 2018	DEFA14A	QHC / Quorum Health Corporation DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro
April 27, 2018	DEF 14A	QHC / Quorum Health Corporation DEF 14A DEF 14A 1 d572530ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as
April 27, 2018	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8-K 1 d580207d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 27, 2018 (April 26, 2018) QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or ot
March 23, 2018	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES BOARD OF DIRECTORS LEADERSHIP TRANSITION EX-99.1 Exhibit 99.1 Investor Contact: Michael J. Culotta Executive Vice President and Chief Financial Officer (615) 221-3502 QUORUM HEALTH CORPORATION ANNOUNCES BOARD OF DIRECTORS LEADERSHIP TRANSITION BRENTWOOD, Tenn. (March 23, 2018) – Quorum Health Corporation (NYSE: QHC) (the “Company”) today announced that William M. Gracey, previously the Chair of the Company’s Board of Directors (“Board”)
March 23, 2018	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 23, 2018 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (
March 20, 2018	8-K	Termination of a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 20, 2018 (March 19, 2018) QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorpor
March 15, 2018	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 qhc-8k20180315.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 15, 2018 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction
March 15, 2018	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES FOURTH QUARTER AND YEAR END 2017 OPERATING RESULTS AND ISSUES 2018 GUIDANCE Exhibit 99.1 Investor Contact: Michael J. Culotta Executive Vice President and Chief Financial Officer (615) 221-3502 QUORUM HEALTH CORPORATION ANNOUNCES FOURTH QUARTER AND YEAR END 2017 OPERATING RESULTS AND ISSUES 2018 GUIDANCE BRENTWOOD, Tenn. (March 15, 2018) – Quorum Health Corporation (NYSE: QHC) (the “Company”) today announced its operating and financial results for the three months and yea
March 15, 2018	EX-10.3	Amendment No. 2, dated as of March 14, 2018, to the Credit Agreement, dated as of April 29, 2106, as amended by Amendment No. 1 to the Credit Agreement, dated as of April 11, 2017, among Quorum Health Corporation, the lenders party thereto and Credit Suisse AG, as Administrative Agent and Collateral Agent exhibit 10.3 Amendment NO. 2 dated as of March 14, 2018 (this “Amendment”), to the Credit Agreement dated as of April 29, 2016, as amended by Amendment No. 1 to the Credit Agreement, dated as of April 11, 2017 (as amended, supplemented or otherwise modified through the date hereof, the “Credit Agreement”), among QUORUM HEALTH CORPORATION, a Delaware corporation (the “Borrower”), the lenders party
March 15, 2018	EX-12.1	Ratio of Earnings to Fixed Charges. Exhibit 12.1 STATEMENT OF COMPUTATION OF EARNINGS TO FIXED CHARGES (Dollars in Thousands) Year ended December 31, 2017 2016 2015 2014 2013 Earnings Income (loss) before income taxes $ (134,222 ) $ (399,072 ) $ 8,039 $ 12,932 $ (37,447 ) Interest and amortization of deferred financing costs 122,077 113,440 98,290 92,926 99,465 Implicit rental interest expense 12,558 12,471 12,182 12,080 10,773 Tota
March 15, 2018	10-K	QHC / Quorum Health Corporation 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37550 QUORUM HEALTH CORPORATION
March 15, 2018	EX-21.1	List of Subsidiaries of Quorum Health Corporation. EX-21.1 4 qhc-ex2119.htm EX-21.1 Exhibit 21.1 Quorum Health Corporation SUBSIDIARY LISTING (*) Majority position held in an entity with physicians, non-profit entities or both Alfaro, Ltd. (NV) Ambulance Services of Forrest City, LLC (AR) Ambulance Services of Lexington, Inc. (TN) Ambulance Services of McKenzie, Inc. (TN) Ambulance Services of Tooele, LLC (DE) Anna Clinic Corp (IL) Anna Hospital C
March 12, 2018	EX-24	EX-24 Exhibit 24 POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints R.
March 7, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 7, 2018 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Commission
March 7, 2018	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES PRELIMINARY FOURTH QUARTER AND YEAR END 2017 OPERATING RESULTS AND INTENTION TO AMEND SENIOR CREDIT FACILITY EX-99.1 Exhibit 99.1 Investor Contact: Michael J. Culotta Executive Vice President and Chief Financial Officer (615) 221-3502 QUORUM HEALTH CORPORATION ANNOUNCES PRELIMINARY FOURTH QUARTER AND YEAR END 2017 OPERATING RESULTS AND INTENTION TO AMEND SENIOR CREDIT FACILITY BRENTWOOD, Tenn. (March 7, 2018) – Quorum Health Corporation (NYSE: QHC) (the “Company”) today announced its preliminary operatin
February 14, 2018	EX-99.1	JOINT FILING AGREEMENT EX-99.1 EXHIBIT 99-1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, $0.0001 par value per share, of Quorum Health Corporation, a Delaware corporation, and furth
February 14, 2018	SC 13G	QHC / Quorum Health Corporation / HIGHLAND CAPITAL MANAGEMENT FUND ADVISORS, L.P. - SC 13G Passive Investment SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 Quorum Health Corporation (Name of Issuer) Common Stock, $0.
February 14, 2018	SC 13G/A	QHC / Quorum Health Corporation / GreenLight Capital Inc Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Quorum Health Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 74909E106 (CUSIP Number) December 31, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate
February 12, 2018	SC 13G/A	QHC / Quorum Health Corporation / DAVIDSON KEMPNER PARTNERS - QUORUM HEALTH CORP Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Quorum Health Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 74909E106 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur
February 9, 2018	SC 13G	QHC / Quorum Health Corporation / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* QUORUM HEALTH CORP (Name of Issuer) Common Stock (Title of Class of Securities) 74909E106 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched
January 30, 2018	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits 8-K 1 d520009d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 30, 2018 (January 29, 2018) QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State
January 30, 2018	EX-99.1	Quorum Health Corporation Announces Mike Culotta to Resign March 2018 and Alfred Lumsdaine to Succeed as Chief Financial Officer EX-99.1 Exhibit 99.1 Quorum Health Corporation Announces Mike Culotta to Resign March 2018 and Alfred Lumsdaine to Succeed as Chief Financial Officer BRENTWOOD, Tenn. January 30, 2018 ? Quorum Health Corporation (NYSE: QHC) today announced that Michael J. Culotta will resign as Executive Vice President and Chief Financial Officer effective March 31, 2018. Mr. Culotta has served as the Company?s Ex
January 30, 2018	EX-10.2	Consultancy Agreement, dated January 30, 2018, by and between QHCCS, LLC and Michael J. Culotta EX-10.2 Exhibit 10.2 CONSULTANCY AGREEMENT Michael Culotta This Consultancy Agreement (?Agreement?) is entered into by and between QHCCS, LLC a Delaware corporation (?QHCCS?), and Michael Culotta (?Consultant?). 1. Work to Be Performed. It is necessary and/or advisable to promote the interests of QHCCS and associated entities that the Consultant provides ongoing consulting services related to Fina
January 30, 2018	EX-10.1	Separation and Release Agreement, dated January 30, 2018, by and between QHCCS, LLC d/b/a Quorum Health and Michael J. Culotta EX-10.1 2 d520009dex101.htm EX-10.1 Exhibit 10.1 SEPARATION AND RELEASE AGREEMENT THIS SEPARATION AND RELEASE AGREEMENT (“Agreement”) is between Michael Culotta (the “Employee”) and QHCCS, LLC, dba Quorum Health (the “Employer”). In consideration of the mutual promises and covenants in this Agreement, the Employee and the Employer contract as follows: 1. Cessation of Employment. The Employee ackno
January 30, 2018	EX-10.3	Employment Offer Letter, dated January 29, 2018, by and between Quorum Health Corporation and Alfred Lumsdaine EX-10.3 4 d520009dex103.htm EX-10.3 Exhibit 10.3 January 29, 2018 Via Email Delivery Alfred Lumsdaine 9723 Concord Pass Brentwood, TN 37027 Dear Alfred: I am pleased to confirm our employment offer for you to join QHCCS, LLC, an affiliate of Quorum Health Corporation (hereinafter referred to as either Quorum Health or Quorum) in the position of Executive Vice President of Finance, reporting to Tom
January 26, 2018	8-K	QHC / Quorum Health Corporation 8-K (Current Report) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 26, 2018 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Com
January 5, 2018	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Costs Associated with Exit or Disposal Activities, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 5, 2018 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Commissi
January 5, 2018	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES CLOSURE OF HOSPITAL IN OHIO qhc-ex99114.htm Exhibit 99.1 Investor Contact: Michael J. Culotta Executive Vice President and Chief Financial Officer (615) 221-3502 QUORUM HEALTH CORPORATION ANNOUNCES CLOSURE OF HOSPITAL IN OHIO BRENTWOOD, Tenn. (January 5, 2018) ? Quorum Health Corporation (NYSE: QHC) today announced plans to close Affinity Medical Center in Massillon, Ohio. Operations will cease at 11:59 p.m. on February 4, 2
November 8, 2017	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 8, 2017 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Commiss
November 8, 2017	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES THIRD QUARTER 2017 OPERATING RESULTS qhc-ex9916.htm Exhibit 99.1 Investor Contact: Michael J. Culotta Executive Vice President and Chief Financial Officer (615) 221-3502 QUORUM HEALTH CORPORATION ANNOUNCES THIRD QUARTER 2017 OPERATING RESULTS BRENTWOOD, Tenn. (November 8, 2017) ? Quorum Health Corporation (NYSE: QHC) (the ?Company?) today announced its operating and financial results for the three and nine months ended September 30,
November 8, 2017	10-Q	QHC / Quorum Health Corporation 10-Q (Quarterly Report) fSep2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37550 QUORUM HEAL
October 2, 2017	EX-24	EX-24 POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints R.
September 29, 2017	EX-10.1	Form of Change in Control Severance Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on September 29, 2017) (File No. 001-37550). EX-10.1 Exhibit 10.1 CHANGE IN CONTROL SEVERANCE AGREEMENT THIS CHANGE IN CONTROL SEVERANCE AGREEMENT is made as of the day of , 2017, by and among Quorum Health Corporation (the ?Corporation?), QHCCS, LLC (the ?Employer?), and (the ?Executive?). WHEREAS, the Board of Directors of the Corporation and the Board of Directors of the Employer (the ?Boards?) recognize that the possibility of a Change i
September 29, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 29, 2017 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.
September 28, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8-K 1 d452218d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 28, 2017 (September 27, 2017) QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or
August 9, 2017	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES SECOND QUARTER 2017 OPERATING RESULTS qhc-ex9916.htm Exhibit 99.1 Investor Contact: Michael J. Culotta Executive Vice President and Chief Financial Officer (615) 221-3502 QUORUM HEALTH CORPORATION ANNOUNCES SECOND QUARTER 2017 OPERATING RESULTS BRENTWOOD, Tenn. (August 9, 2017) ? Quorum Health Corporation (NYSE: QHC) (the ?Company?) today announced its operating and financial results for the three and six months ended June 30, 2017. N
August 9, 2017	8-K	Quorum Health 8-K (Current Report/Significant Event) qhc-8k20170809.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 9, 2017 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction of incorp
August 9, 2017	10-Q	QHC / Quorum Health Corporation 10-Q (Quarterly Report) fSep2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37550 QUORUM HEALTH CO
June 6, 2017	EX-99.1	JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT This Joint Filing Agreement, dated as of June 6, 2017 is by and among North Tide Capital Master, LP, North Tide Capital, LLC and Conan Laughlin, an individual (the foregoing are collectively referred to herein as the “Filers”). Each of the Filers may be required to file with the United States Securities and Exchange Commission a statement on Schedule 13D and/or
June 6, 2017	SC 13G/A	QHC / Quorum Health Corporation / North Tide Capital Master, LP Passive Investment SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* QUORUM HEALTH CORPORATION (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 74909E106 (CUSIP Number) May 18, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [x] Rule 13d-1(c)
May 22, 2017	SC 13D/A	QHC / Quorum Health Corporation / KKR Asset Management LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934* (Amendment No. 2) Quorum Health Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 74909E106 (CUSIP Number) David J. Sorkin, Esq. Kohlberg Kravis Roberts & Co. L.P. 9 West 57th Street, Suite 4200 New York, NY 10019 (212)
May 16, 2017	8-K	Submission of Matters to a Vote of Security Holders 8-K 1 d390965d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 16, 2017 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction
May 15, 2017	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 qhc-8k20170331.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 15, 2017 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdiction o
May 15, 2017	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES FIRST QUARTER 2017 OPERATING RESULTS qhc-ex9916.htm Exhibit 99.1 Investor Contact: Michael J. Culotta Executive Vice President and Chief Financial Officer (615) 221-3502 QUORUM HEALTH CORPORATION ANNOUNCES FIRST QUARTER 2017 OPERATING RESULTS BRENTWOOD, Tenn. (May 15, 2017) – Quorum Health Corporation (NYSE: QHC) (the “Company”) today announced its operating and financial results for the three months ended March 31, 2017. Net operati
May 15, 2017	10-Q	Quorum Health 10-Q (Quarterly Report) qhc-10q20170331.htm fSep2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-3
April 17, 2017	424B3	Quorum Health Corporation Offers to Exchange 424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-217277 PROSPECTUS Quorum Health Corporation Offers to Exchange up to $400,000,000 in aggregate principal amount of 11.625% Senior Notes due 2023 (the Exchange Notes), which have been registered under the Securities Act of 1933, as amended (the Securities Act), for any and all outstanding unregistered 11.625% Senior N
April 17, 2017	EX-99.1	Quorum Health Corporation Announces Launch of Exchange Offer For 11.625% Senior Notes due 2023 EX-99.1 Exhibit 99.1 Quorum Health Corporation Announces Launch of Exchange Offer For 11.625% Senior Notes due 2023 BRENTWOOD, Tenn. April 17, 2017 ? Quorum Health Corporation (the ?Company?)(NYSE: QHC) today announced that it has launched an offer to exchange its 11.625% Senior Notes due 2023 in the aggregate principal amount of $400,000,000, which are not registered under the Securities Act of 1
April 17, 2017	8-K	Financial Statements and Exhibits, Other Events 8-K 1 d379807d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 17, 2017 QUORUM HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-37550 47-4725208 (State or other jurisdictio
April 13, 2017	DEF 14A	Quorum Health DEF 14A DEF 14A 1 d372327ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as
April 12, 2017	10-K	Quorum Health 10-K (Annual Report) qhc-10k20161231.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37550 QUORUM
April 12, 2017	EX-3.74	FIRST AMENDMENT TO THE LIMITED LIABILITY COMPANY AGREEMENT QUORUM HEALTH INVESTMENT COMPANY, LLC EX-3.74 15 d334690dex374.htm EX-3.74 Exhibit 3.74 FIRST AMENDMENT TO THE LIMITED LIABILITY COMPANY AGREEMENT OF QUORUM HEALTH INVESTMENT COMPANY, LLC THIS FIRST AMENDMENT (“Amendment”) is entered into to be effective as of April 29, 2016 by Quorum Health Corporation, a Delaware corporation (the “Member”). WHEREAS, the Member desires to amend that certain Limited Liability Company Agreement effecti
April 12, 2017	EX-3.64	THIRD AMENDMENT TO THE AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT MWMC HOLDINGS, LLC EX-3.64 11 d334690dex364.htm EX-3.64 Exhibit 3.64 THIRD AMENDMENT TO THE AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF MWMC HOLDINGS, LLC THIS FIRST AMENDMENT (“Amendment”) is entered into to be effective as of December 31, 2015 by and between Quorum Health Investment Company, LLC, a Delaware limited liability company, and Triad of Oregon, LLC, a Delaware limited liability company (t
April 12, 2017	EX-23.12	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 23.12 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in this Registration Statement on Form S-4 of our report dated April 12, 2017 relating to the financial statements of Quorum Health Corporation and subsidiaries, appearing in the Prospectus, which is part of this Registration Statement. We also consent to the reference to us under the heading ?Experts? in
April 12, 2017	EX-3.58	FIRST AMENDMENT TO THE AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT MCKENZIE TENNESSEE HOSPITAL COMPANY, LLC EX-3.58 8 d334690dex358.htm EX-3.58 Exhibit 3.58 FIRST AMENDMENT TO THE AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF MCKENZIE TENNESSEE HOSPITAL COMPANY, LLC THIS FIRST AMENDMENT (“Amendment”) is entered into to be effective as of April 29, 2016 by Quorum Health Corporation, a Delaware corporation (the “Member”). WHEREAS, the Member desires to amend that certain Amended and Restated
April 12, 2017	EX-99.3	QUORUM HEALTH CORPORATION OFFER TO EXCHANGE $400,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 11.625% SENIOR NOTES DUE 2023, WHICH HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), FOR ANY AND ALL OF ITS OUTSTANDI EX-99.3 36 d334690dex993.htm EX-99.3 Exhibit 99.3 QUORUM HEALTH CORPORATION OFFER TO EXCHANGE $400,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 11.625% SENIOR NOTES DUE 2023, WHICH HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), FOR ANY AND ALL OF ITS OUTSTANDING UNREGISTERED 11.625% SENIOR NOTES DUE 2023 (CUSIP Nos. 74909EAA4 and U7490CAA0) , 2017 To Our Cli
April 12, 2017	EX-5.11	April 12, 2017 Exhibit 5.11 April 12, 2017 Quorum Health Corporation 1573 Mallory Lane, Suite 100 Brentwood, Tennessee 37027 Re: Registration Statement on Form S-4 Ladies and Gentlemen: We have acted as New York counsel to Quorum Health Corporation (the ?Issuer?) and the entities identified on Exhibit A attached to this letter (collectively the ?Guarantors?) solely for the purpose of providing the opinions set f
April 12, 2017	EX-99.4	QUORUM HEALTH CORPORATION NOTICE OF GUARANTEED DELIVERY OFFER TO EXCHANGE $400,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 11.625% SENIOR NOTES DUE 2023, WHICH HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), FO Exhibit 99.4 QUORUM HEALTH CORPORATION NOTICE OF GUARANTEED DELIVERY OFFER TO EXCHANGE $400,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 11.625% SENIOR NOTES DUE 2023, WHICH HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), FOR ANY AND ALL OF ITS OUTSTANDING UNREGISTERED 11.625% SENIOR NOTES DUE 2023 (CUSIP Nos. 74909EAA4 and U7490CAA0) Dated , 2017 The Exchang
April 12, 2017	EX-5.6	April 12, 2017 Exhibit 5.6 April 12, 2017 Quorum Health Corporation 1573 Mallory Lane Brentwood, Tennessee 37027 Ladies and Gentlemen: We have acted as special counsel in the State of Ohio and the Commonwealth of Kentucky (collectively, the ?States?) to Quorum Health Corporation, a Delaware corporation, (the ?Company?) and the Guarantors (as defined below), each respectively organized and existing under the laws
April 12, 2017	EX-3.88	FIRST AMENDMENT TO THE AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT TRIAD OF OREGON, LLC EX-3.88 19 d334690dex388.htm EX-3.88 Exhibit 3.88 FIRST AMENDMENT TO THE AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF TRIAD OF OREGON, LLC THIS FIRST AMENDMENT (“Amendment”) is entered into to be effective as of December 31, 2015 by QUORUM HEALTH INVESTMENT COMPANY, LLC, a Delaware limited liability company (the “Member”). WHEREAS, the Member desires to amend that certain Amended an
April 12, 2017	EX-3.40	LIMITED LIABILITY COMPANY AGREEMENT QHCCS, LLC September 25, 2015 TABLE OF CONTENTS EX-3.40 7 d334690dex340.htm EX-3.40 Exhibit 3.40 LIMITED LIABILITY COMPANY AGREEMENT OF QHCCS, LLC September 25, 2015 TABLE OF CONTENTS Section 1. FORMATION 1 1.1 Formation 1 2. NAME AND OFFICE 1 2.1 Name 1 2.2 Principal Office 1 3. PURPOSE AND TERM 1 3.1 Purpose 1 3.2 Company’s Power 1 3.3 Term 1 4. CAPITAL 2 4.1 Initial Capital Contribution of Member 2 4.2 No Liability of Member 2 4.3 No Interes
April 12, 2017	EX-3.18	FIRST AMENDMENT TO THE LIMITED LIABILITY COMPANY AGREEMENT CSRA HOLDINGS, LLC EX-3.18 5 d334690dex318.htm EX-3.18 Exhibit 3.18 FIRST AMENDMENT TO THE LIMITED LIABILITY COMPANY AGREEMENT OF CSRA HOLDINGS, LLC THIS FIRST AMENDMENT (“Amendment”) is entered into to be effective as of December 31, 2015 by Quorum Health Investment Company, LLC, a Delaware limited liability company (the “Member”). WHEREAS, the Member desires to amend that certain Limited Liability Company Agreemen
April 12, 2017	EX-21.1	Quorum Health Corporation SUBSIDIARY LISTING Exhibit 21.1 Quorum Health Corporation SUBSIDIARY LISTING (*) Majority position held in an entity with physicians, non-profit entities or both Alfaro, Ltd. (NV) Ambulance Services of Forrest City, LLC (AR) Ambulance Services of Lexington, Inc. (TN) Ambulance Services of McKenzie, Inc. (TN) Ambulance Services of Tooele, LLC (DE) Anna Clinic Corp (IL) Anna Hospital Corporation (IL) d/b/a Union Count
April 12, 2017	EX-10.4	Amendment No. 1, dated as of April 11, 2017, to the ABL Credit Agreement, dated as of April 29, 2016, by and among Quorum Health Corporation, the lenders party thereto and UBS AG, Stamford Branch, as Administrative Agent, Collateral Agent and Swingline Lender (incorporated by reference to Exhibit 10.4 to the Company’s Annual Report on Form 10-K filed with the SEC on April 12, 2017) (File No. 001-37550). Exhibit 10.4 Amendment NO. 1 dated as of April 11, 2017 (this “Amendment”), to the ABL Credit Agreement dated as of April 29, 2016 (the “Credit Agreement”), among QUORUM HEALTH CORPORATION, a Delaware corporation (the “Borrower”), the lenders party thereto (the “Lenders”) and UBS AG, STAMFORD BRANCH, as administrative agent (in such capacity, the “Administrative Agent”) and as collateral agent for
April 12, 2017	EX-5.5	April 12, 2017 Exhibit 5.5 McGuireWoods LLP 77 West Wacker Drive Suite 4100 Chicago, IL 60601-1818 Phone: 312.849.8100 Fax: 312.849.3690 www.mcguirewoods.com April 12, 2017 Quorum Health Corporation 1573 Mallory Lane Brentwood, Tennessee 37027 Re: Offer and exchange of 11.625% Senior Notes due 2023 of Quorum Health Corporation Ladies and Gentlemen: We are delivering this opinion letter at the request of Quorum H
April 12, 2017	EX-3.73	State of Delaware Secretary of State Division of Corporations Delivered 03:58 PM 09/28/2015 FILED 03:58 PM 09/28/2015 SR 20150292167 - File Number 5835815 Exhibit 3.73 State of Delaware Secretary of State Division of Corporations Delivered 03:58 PM 09/28/2015 FILED 03:58 PM 09/28/2015 SR 20150292167 - File Number 5835815 STATE of DELAWARE LIMITED LIABILITY COMPANY CERTIFICATE of FORMATION First: The name of the limited liability company is QHG GA-OH Holdings, LLC Second: The address of its registered office in the State of Delaware is 2711 Centervil
April 12, 2017	EX-12.1	STATEMENT RE: COMPUTATION OF EARNINGS TO FIXED CHARGES (DOLLARS IN THOUSANDS) Exhibit 12.1 STATEMENT RE: COMPUTATION OF EARNINGS TO FIXED CHARGES (DOLLARS IN THOUSANDS) Year ended December 31, 2016 2015 2014 2013 2012 Earnings Add: Income (loss) before income taxes $ (399,072 ) $ 8,039 $ 12,932 $ (37,447 ) $ (12,917 ) Interest and amortization of deferred financing costs 113,440 98,290 92,926 99,465 97,942 Implicit rental interest expense 12,471 12,182 12,080 10,773 9,947 T
April 12, 2017	EX-3.13	State of Delaware Secretary of State Division of Corporations Delivered 03:58 PM 09/28/2015 FILED 03:58 PM 09/28/2015 SR 20150292165 - File Number 5835805 EX-3.13 3 d334690dex313.htm EX-3.13 Exhibit 3.13 State of Delaware Secretary of State Division of Corporations Delivered 03:58 PM 09/28/2015 FILED 03:58 PM 09/28/2015 SR 20150292165 - File Number 5835805 STATE of DELAWARE LIMITED LIABILITY COMPANY CERTIFICATE of FORMATION First: The name of the limited liability company is Blue Ridge Georgia Holdings, LLC Second: The address of its registered offi
April 12, 2017	EX-3.62	FIRST AMENDMENT TO THE SECOND AMENDED AND RESTATED OPERATING AGREEMENT MONROE HMA, LLC EX-3.62 10 d334690dex362.htm EX-3.62 Exhibit 3.62 FIRST AMENDMENT TO THE SECOND AMENDED AND RESTATED OPERATING AGREEMENT OF MONROE HMA, LLC THIS FIRST AMENDMENT (“Amendment”) is entered into to be effective as of December 31, 2015 by Quorum Health Investment Company, LLC, a Delaware limited liability company (the “Member”). WHEREAS, the Member desires to amend that certain Second Amended and Resta
April 12, 2017	EX-3.76	FIRST AMENDMENT TO THE LIMITED LIABILITY COMPANY AGREEMENT QUORUM HEALTH RESOURCES, LLC EX-3.76 16 d334690dex376.htm EX-3.76 Exhibit 3.76 FIRST AMENDMENT TO THE LIMITED LIABILITY COMPANY AGREEMENT OF QUORUM HEALTH RESOURCES, LLC THIS FIRST AMENDMENT (“Amendment”) is entered into to be effective as of December 31, 2015 by Quorum Health Investment Company, LLC, a Delaware limited liability company (the “Member”). WHEREAS, the Member desires to amend that certain Limited Liability Compa
April 12, 2017	EX-3.83	State of Delaware Secretary of State Division of Corporations Delivered 02:15 PM 10/17/2007 FILED 02:15 PM 10/17/2007 SRV 071125752 - 4442354 FILE EX-3.83 17 d334690dex383.htm EX-3.83 Exhibit 3.83 State of Delaware Secretary of State Division of Corporations Delivered 02:15 PM 10/17/2007 FILED 02:15 PM 10/17/2007 SRV 071125752 - 4442354 FILE STATE of DELAWARE LIMITED LIABILITY COMPANY CERTIFICATE of FORMATION • First: The name of the limited liability company is Sunbury Hospital Company, LLC. • Second: The address of its registered office in
April 12, 2017	EX-3.84	FIRST AMENDMENT TO THE SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT SUNBURY HOSPITAL COMPANY, LLC EX-3.84 18 d334690dex384.htm EX-3.84 Exhibit 3.84 FIRST AMENDMENT TO THE SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF SUNBURY HOSPITAL COMPANY, LLC THIS FIRST AMENDMENT (“Amendment”) is entered into to be effective as of April 29, 2016 by Quorum Health Corporation, a Delaware corporation (the “Member”). WHEREAS, the Member desires to amend that certain Second Amended and Rest
April 12, 2017	EX-5.3	KUTAK ROCK LLP Suite 136 3300 Market Street ROGERS, ARKANSAS 72758-8127 FACSIMILE 479-316-4069 Exhibit 5.3 KUTAK ROCK LLP Suite 136 3300 Market Street ROGERS, ARKANSAS 72758-8127 479-250-9700 FACSIMILE 479-316-4069 www.kutakrock.com ATLANTA CHICAGO DENVER FAYETTEVILLE IRVINE KANSAS CITY LITTLE ROCK LOS ANGELES MINNEAPOLIS OKLAHOMA CITY OMAHA PHILADELPHIA RICHMOND SCOTTSDALE SPOKANE WASHINGTON, D.C. April 12, 2017 WICHITA Quorum Health Corporation 1573 Mallory Lane Brentwood, Tennessee 37027
April 12, 2017	EX-10.2	Amendment No. 1, dated as of April 11, 2017, to the Credit Agreement, dated as of April 29, 2016, among Quorum Health Corporation, the lenders party thereto and Credit Suisse AG, as Administrative Agent and Collateral Agent (incorporated by reference to Exhibit 10.2 to the Company’s Annual Report on Form 10-K filed with the SEC on April 12, 2017) (File No. 001-37550). Exhibit 10.2 AMENDMENT NO. 1 dated as of April 11, 2017 (this “Amendment”), to the CREDIT AGREEMENT dated as of April 29, 2016 (as amended, supplemented or otherwise modified through the date hereof, the “Credit Agreement”), among QUORUM HEALTH CORPORATION, a Delaware corporation (the “Borrower”), the lenders party thereto (the “Lenders”) and CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, as administrat
April 12, 2017	EX-3.12	FIRST AMENDMENT TO THE LIMITED LIABILITY COMPANY AGREEMENT BLUE ISLAND ILLINOIS HOLDINGS, LLC EX-3.12 2 d334690dex312.htm EX-3.12 Exhibit 3.12 FIRST AMENDMENT TO THE LIMITED LIABILITY COMPANY AGREEMENT OF BLUE ISLAND ILLINOIS HOLDINGS, LLC THIS FIRST AMENDMENT (“Amendment”) is entered into to be effective as of April 29, 2016 by Quorum Health Corporation, a Delaware corporation (the “Member”). WHEREAS, the Member desires to amend that certain Limited Liability Company Agreement effective N
April 12, 2017	EX-5.4	* * * * * Exhibit 5.4 1180 Peachtree Street Atlanta, Georgia 30309 www.kslaw.com King & Spalding LLP Direct Dial: 404/572-4600 Direct Fax: 404/572-5132 www.kslaw.com April 12, 2017 Quorum Health Corporation 1573 Mallory Lane Brentwood, Tennessee 37027 Ladies and Gentlemen: We have acted as special Georgia counsel to Monroe HMA, LLC, a Georgia limited liability company (the ?Georgia Guarantor?), in connectio
April 12, 2017	EX-99.2	QUORUM HEALTH CORPORATION OFFER TO EXCHANGE $400,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 11.625% SENIOR NOTES DUE 2023, WHICH HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), FOR ANY AND ALL OF ITS OUTSTANDI EX-99.2 35 d334690dex992.htm EX-99.2 Exhibit 99.2 QUORUM HEALTH CORPORATION OFFER TO EXCHANGE $400,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 11.625% SENIOR NOTES DUE 2023, WHICH HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), FOR ANY AND ALL OF ITS OUTSTANDING UNREGISTERED 11.625% SENIOR NOTES DUE 2023 (CUSIP Nos. 74909EAA4 and U7490CAA0) , 2017 To Brokers
April 12, 2017	EX-5.9	EMMETT BERRYMAN April 12, 2017 SENDER’S E-MAIL: [email protected] Exhibit 5.9 EMMETT BERRYMAN April 12, 2017 SENDER?S E-MAIL: [email protected] Quorum Health Corporation 1573 Mallory Lane Brentwood, Tennessee 37027 Ladies and Gentlemen: We have acted as Texas counsel to Quorum Health Corporation (the ?Company?) and the Guarantors (as defined below), each organized and existing under the laws of the State of Texas, in connection with the filing by the Compa
April 12, 2017	EX-4.3	Supplemental Indenture, dated as of December 28, 2016, by and among Quorum Health Corporation, the guarantor party thereto and Regions Bank, as trustee (incorporated by reference to Exhibit 4.3 to the Company’s Annual Report on Form 10-K filed with the SEC on April 12, 2017) (File No. 001-37550). Exhibit 4.3 SUPPLEMENTAL INDENTURE, (this “Supplemental Indenture”) dated as of December 28, 2016, by and among Quorum Health Corporation, a Delaware corporation (“Issuer”), the parties that are signatories hereto as Guarantors (each a “Guaranteeing Subsidiary”) and Regions Bank, as Trustee under the Indenture referred to below. W I T N E S S E T H: WHEREAS, each of the Issuer, the Guarantors and
April 12, 2017	EX-99.1	QUORUM HEALTH CORPORATION LETTER OF TRANSMITTAL OFFER TO EXCHANGE $400,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 11.625% SENIOR NOTES DUE 2023, WHICH HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), FOR ANY AN EX-99.1 34 d334690dex991.htm EX-99.1 Exhibit 99.1 QUORUM HEALTH CORPORATION LETTER OF TRANSMITTAL OFFER TO EXCHANGE $400,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 11.625% SENIOR NOTES DUE 2023, WHICH HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), FOR ANY AND ALL OF ITS OUTSTANDING UNREGISTERED 11.625% SENIOR NOTES DUE 2023 (CUSIP Nos. 74909EAA4 and U7490C
April 12, 2017	EX-5.10	April 12, 2017 Exhibit 5.10 490 North 31st Street P.O. Box 2529 Billings, MT 59103-2529 Ph: 406.252-3441 Fx: 406.252-3181 April 12, 2017 Quorum Health Corporation 1573 Mallory Lane Brentwood, Tennessee 37027 Ladies and Gentlemen: We have acted as Wyoming counsel to Quorum Health Corporation (the ?Company?) and the Guarantor (as defined below), organized and existing under the laws of the State of Wyoming, in con
April 12, 2017	EX-3.70	LIMITED LIABILITY COMPANY AGREEMENT QHC CALIFORNIA HOLDINGS, LLC March 30, 2016 TABLE OF CONTENTS Section 1. FORMATION 1 1.1 Formation 1 2. NAME AND OFFICE 1 2.1 Name 1 2.2 Principal Office 1 3. PURPOSE AND TERM 1 3.1 Purpose 1 3.2 Company’s Power 1 EX-3.70 13 d334690dex370.htm EX-3.70 Exhibit 3.70 LIMITED LIABILITY COMPANY AGREEMENT OF QHC CALIFORNIA HOLDINGS, LLC March 30, 2016 TABLE OF CONTENTS Section 1. FORMATION 1 1.1 Formation 1 2. NAME AND OFFICE 1 2.1 Name 1 2.2 Principal Office 1 3. PURPOSE AND TERM 1 3.1 Purpose 1 3.2 Company’s Power 1 3.3 Term 1 4. CAPITAL 2 4.1 Initial Capital Contribution of Member 2 4.2 No Liability of Member 2
April 12, 2017	EX-3.69	State of Delaware Secretary of State Division of Corporations Delivered 05:26 PM 03/30/2016 FILED 05:26 PM 03/30/2016 SR 20161976299 - File Number 6003724 EX-3.69 12 d334690dex369.htm EX-3.69 Exhibit 3.69 State of Delaware Secretary of State Division of Corporations Delivered 05:26 PM 03/30/2016 FILED 05:26 PM 03/30/2016 SR 20161976299 - File Number 6003724 STATE of DELAWARE LIMITED LIABILITY COMPANY CERTIFICATE OF FORMATION First: The name of the limited liability company is QHC California Holdings, LLC. Second: The address of its registered office
April 12, 2017	EX-3.14	FIRST AMENDMENT TO THE LIMITED LIABILITY COMPANY AGREEMENT BLUE RIDGE GEORGIA HOLDINGS, LLC EX-3.14 4 d334690dex314.htm EX-3.14 Exhibit 3.14 FIRST AMENDMENT TO THE LIMITED LIABILITY COMPANY AGREEMENT OF BLUE RIDGE GEORGIA HOLDINGS, LLC THIS FIRST AMENDMENT (“Amendment”) is entered into to be effective as of April 29, 2016 by Quorum Health Corporation, a Delaware corporation (the “Member”). WHEREAS, the Member desires to amend that certain Limited Liability Company Agreement effective Sep
April 12, 2017	EX-5.7	April 12, 2017 Exhibit 5.7 SUZANNE C. ODOM Direct: (505) 986-2659 Cell: (505) 699-4253 Email: [email protected] www.montand.com April 12, 2017 Quorum Health Corporation 1573 Mallory Lane Brentwood, Tennessee 37027 Ladies and Gentlemen: We have acted as special New Mexico counsel to Quorum Health Corporation (the ?Company?), and the New Mexico Guarantors (as defined below), each organized and existing under the law
April 12, 2017	EX-25.1	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE EX-25.1 33 d334690dex251.htm EX-25.1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b) (2) REGIONS BANK (Exact name of trustee as specified in its charter)
April 12, 2017	EX-3.60	FIRST AMENDMENT TO THE AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT MMC OF NEVADA, LLC Exhibit 3.60 FIRST AMENDMENT TO THE AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF MMC OF NEVADA, LLC THIS FIRST AMENDMENT (?Amendment?) is entered into to be effective as of December 31, 2015 by QUORUM HEALTH INVESTMENT COMPANY, LLC, a Delaware limited liability company (the ?Member?). WHEREAS, the Member desires to amend that certain Amended and Restated Limited Liability Company Ag
April 12, 2017	EX-4.6	Registration Rights Agreement Joinder, dated as of December 28, 2016, by and between the guarantor party thereto and Credit Suisse Securities (USA) LLC, as representative of the initial purchasers (incorporated by reference to Exhibit 4.6 to the Company’s Annual Report on Form 10-K filed with the SEC on April 12, 2017) (File No. 001-37550). Exhibit 4.6 Quorum Health Corporation $400,000,000 11.625% Senior Notes due 2023 REGISTRATION RIGHTS JOINDER December 28, 2016 Credit Suisse Securities (USA) LLC, As Representative of the several Initial Purchasers, C/O Credit Suisse Securities (USA) LLC Eleven Madison Avenue New York, New York 10010 Ladies and Gentlemen: Reference is made to the Registration Rights Agreement (the “Registration Ri
April 12, 2017	EX-3.39	State of Delaware Secretary of State Division of Corporations Delivered 11:50 AM 09/25/2015 FILED 11:50 AM 09/25/2015 SR 20150266652 - File Number 5833369 EX-3.39 6 d334690dex339.htm EX-3.39 Exhibit 3.39 State of Delaware Secretary of State Division of Corporations Delivered 11:50 AM 09/25/2015 FILED 11:50 AM 09/25/2015 SR 20150266652 - File Number 5833369 STATE of DELAWARE LIMITED LIABILITY COMPANY CERTIFICATE of FORMATION First: The name of the limited liability company is QHCCS, LLC Second: The address of its registered office in the State of Del
April 12, 2017	EX-12.1	STATEMENT RE: COMPUTATION OF EARNINGS TO FIXED CHARGES (DOLLARS IN THOUSANDS) Year ended December 31, 2016 2015 2014 2013 2012 Earnings Add: Income (loss) before income taxes $ (399,072 ) $ 8,039 $ 12,932 $ (37,447 ) $ (12,917 ) Interest and amortiza Exhibit 12.1 STATEMENT RE: COMPUTATION OF EARNINGS TO FIXED CHARGES (DOLLARS IN THOUSANDS) Year ended December 31, 2016 2015 2014 2013 2012 Earnings Add: Income (loss) before income taxes $ (399,072 ) $ 8,039 $ 12,932 $ (37,447 ) $ (12,917 ) Interest and amortization of deferred financing costs 113,440 98,290 92,926 99,465 97,942 Implicit rental interest expense 12,471 12,182 12,080 10,773 9,947 T
April 12, 2017	EX-5.8	— — — — — — — — — — — Exhibit 5.8 ? ? ? ? ? ? ? ? ? ? ? 1735 Market Street, 51st Floor Philadelphia, PA 19103-7599 TEL 215.665.8500 FAX 215.864.8999 www.ballardspahr.com April 12, 2017 Quorum Health Corporation 1573 Mallory Lane Brentwood, Tennessee 37027 Ladies and Gentlemen: We have acted as Pennsylvania and Utah counsel to Quorum Health Corporation (the ?Company?) and the Guarantors (as defined below), in connection
April 12, 2017	S-4	As filed with the Securities and Exchange Commission on April 12, 2017 Table of Contents As filed with the Securities and Exchange Commission on April 12, 2017 Registration No.
April 11, 2017	SC 13D/A	QHC / Quorum Health Corporation / KKR Asset Management LLC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934* (Amendment No. 1) Quorum Health Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 74909E106 (CUSIP Number) David J. Sorkin, Esq. Kohlberg Kravis Roberts & Co. L.P. 9 West 57th Street, Suite 4200 New York, NY 10019 (212)
April 5, 2017	8-K	Quorum Health FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 5, 2017 QUORUM HEALTH CORPORATION (Exact name of Registrant as Specified in Its Charter) Delaware 001-37550 47-4725208 (State or Other Jurisdiction of Incorporation) (C
March 30, 2017	SC 13D	QHC / Quorum Health Corporation / KKR Asset Management LLC - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934* (Amendment No. ) Quorum Health Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 74909E106 (CUSIP Number) David J. Sorkin, Esq. Kohlberg Kravis Roberts & Co. L.P. 9 West 57th Street, Suite 4200 New York, NY 10019 (212) 7
March 29, 2017	EX-99.1	QUORUM HEALTH CORPORATION ANNOUNCES FOURTH QUARTER AND YEAR END 2016 OPERATING RESULTS AND ISSUES 2017 GUIDANCE qhc-ex9916.htm Exhibit 99.1 Investor Contact: Michael J. Culotta Executive Vice President and Chief Financial Officer (615) 221-3502 QUORUM HEALTH CORPORATION ANNOUNCES FOURTH QUARTER AND YEAR END 2016 OPERATING RESULTS AND ISSUES 2017 GUIDANCE BRENTWOOD, Tenn. (March 29, 2017) ? Quorum Health Corporation (NYSE: QHC) (the ?Company?) today announced its operating and financial results for the three
March 29, 2017	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 29, 2017 QUORUM HEALTH CORPORATION (Exact name of Registrant as Specified in Its Charter) Delaware 001-37550 47-4725208 (State or Other Jurisdiction of Incorporation) (Commissio
March 29, 2017	NT 10-K	Quorum Health NT 10-K NT 10-K 1 d368360dnt10k.htm NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2016 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Repor

QHC / Quorum Health Corporation - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)